Teva Pharmaceutical Industries Ltd (TEVA) is a Healthcare stock tracked by StreetAlpha. It last closed at $41.25 on Oct 13, up 0.19% on the day. TEVA reports earnings on Tue, Nov 3, 2026. The average 12-month price target from 7 analysts is $47.71 (+15.7% from the last close), with a high of $55.00 and a low of $42.00. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (7 buy, 0 hold, 0 sell). In the past 30 days there were 8 dark pool prints totaling $9.1M, the largest $2.7M.
Each firm's latest rating on TEVA in the past 90 days
Average 12-month target
$47.71
▲ 15.7% upside
Based on 7 analysts who set a price target on TEVA in the past 90 days. The average target is $47.71, with a high of $55.00 and a low of $42.00, compared with the last close of $41.25.
Highest target$55.00
Average target$47.71
Lowest target$42.00
Latest rating changes
JP MorganMaintained
Oct 12Buy$50
TD CowenInitiated
Oct 1Buy$55
OppenheimerInitiated
Sep 23Buy$50
Leerink PartnersInitiated
Sep 9Buy$45
UBSMaintained
Sep 4Buy$48
Date
Firm
Action
Rating
Price target
Oct 12
JP Morgan
Maintained
Buy
$50
Oct 1
TD Cowen
Initiated
Buy
$55
Sep 23
Oppenheimer
Initiated
Buy
$50
Sep 9
Leerink Partners
Initiated
Buy
$45
Sep 4
UBS
Maintained
Buy
$48
Loading…
Whale Options Flow
90D
Total alerts
0
Bullish
0
0%
Bearish
0
0%
Date span
—
Loading…
Dark Pool
30D
Prints
8
Notional
$9.1M
Largest print
$2.7M
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TEVA is in one of them and how their past TEVA trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
